【2h】

Neuronal regulation of tendon homoeostasis

机译:肌腱稳态的神经元调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The regulation of tendon homoeostasis, including adaptation to loading, is still not fully understood. Accumulating data, however, demonstrates that in addition to afferent (sensory) functions, the nervous system, via efferent pathways which are associated with through specific neuronal mediators plays an active role in regulating pain, inflammation and tendon homeostasis. This neuronal regulation of intact-, healing- and tendinopathic tendons has been shown to be mediated by three major groups of molecules including opioid, autonomic and excitatory glutamatergic neuroregulators. In intact healthy tendons the neuromediators are found in the surrounding structures: paratenon, endotenon and epitenon, whereas the proper tendon itself is practically devoid of neurovascular supply. This neuroanatomy reflects that normal tendon homoeostasis is regulated from the tendon surroundings. After injury and during tendon repair, however, there is extensive nerve ingrowth into the tendon proper, followed by a time-dependent emergence of sensory, autonomic and glutamatergic mediators, which amplify and fine-tune inflammation and regulate tendon regeneration. In tendinopathic condition, excessive and protracted presence of sensory and glutamatergic neuromediators has been identified, suggesting involvement in inflammatory, nociceptive and hypertrophic (degenerative) tissue responses. Under experimental and clinical conditions of impaired (e.g. diabetes) as well as excessive (e.g. tendinopathy) neuromediator release, dysfunctional tendon homoeostasis develops resulting in chronic pain and gradual degeneration. Thus there is a prospect that in the future pharmacotherapy and tissue engineering approaches targeting neuronal mediators and their receptors may prove to be effective therapies for painful, degenerative and traumatic tendon disorders.
机译:肌腱稳态的调节,包括对负荷的适应,仍未完全了解。但是,越来越多的数据表明,除了传入(感觉)功能外,神经系统还通过特定神经元介体相关的传出途径在调节疼痛,炎症和肌腱稳态方面发挥了积极作用。完整,愈合和肌腱性肌腱的这种神经元调节已显示出由三类主要分子介导,包括阿片样物质,自主神经和兴奋性谷氨酸能神经调节剂。在完整的健康肌腱中,神经介体存在于周围的结构中:对位肌,肌腱和上肌腱,而正确的肌腱本身几乎没有神经血管供应。这种神经解剖学反映出正常的肌腱同调受肌腱周围环境的调节。但是,在受伤后和腱修复过程中,大量神经向腱内生长,然后随时间出现感觉,自主和谷氨酸能介导物,这些介导物放大并微调炎症并调节肌腱再生。在肌腱病病情中,已确定过度和长期存在感觉和谷氨酸能神经介质,提示其参与炎症,伤害性和肥大性(变性)组织反应。在受损的(例如糖尿病)和过度的(例如肌腱病)神经介质释放的实验和临床条件下,功能失调的肌腱稳态发展导致慢性疼痛和逐渐退化。因此,在未来,以神经元介体及其受体为目标的药物治疗和组织工程学方法有望被证明是治疗疼痛,退化和创伤性肌腱疾病的有效疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号